Cargando…
Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines
BACKGROUND: One key approach for anticancer therapy is drug combination. Drug combinations can help reduce doses and thereby decrease side effects. Furthermore, the likelihood of drug resistance is reduced. Distinct alterations in tumor metabolism have been described in past decades, but metabolism...
Autores principales: | Parczyk, Jonas, Ruhnau, Jérôme, Pelz, Carsten, Schilling, Max, Wu, Hao, Piaskowski, Nicole Nadine, Eickholt, Britta, Kühn, Hartmut, Danker, Kerstin, Klein, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086110/ https://www.ncbi.nlm.nih.gov/pubmed/33931028 http://dx.doi.org/10.1186/s12885-021-08186-9 |
Ejemplares similares
-
Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism
por: Ruhnau, Jérôme, et al.
Publicado: (2020) -
HIF1A inhibitor PX-478 reduces pathological stretch-induced calcification and collagen turnover in aortic valve
por: Salim, Md Tausif, et al.
Publicado: (2022) -
Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin
por: Ishiguro, Tatsuaki, et al.
Publicado: (2022) -
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
por: Zhao, Tiansuo, et al.
Publicado: (2014) -
Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
por: Zhao, Tiansuo, et al.
Publicado: (2019)